Company news
ALPS Group Inc news in 2026
ALPS Group Inc's news releases, calls and decks from 2026, newest first.
Alps Group Inc Announces Shareholder Approval for a Share Consolidation, Share Capital Increase, and Adoption of Second Amended and Restated Memorandum and Articles of Association
October 30, 2026
Alps Group Inc Reports Fiscal Year 2026 Financial Results and Provides Business Update
August 7, 2026
Alps Group Inc Launches Patient-Derived Organoid Program to Advance Personalized Cancer Care in Southeast Asia
June 23, 2026
Alps Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189: 2022
June 8, 2026
Alps Group Inc Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
May 18, 2026
Alps Group Appoints Former Ernst & Young Partner to Board of Directors, Strengthening Governance and Capital Markets Oversight
April 16, 2026
Alps Group Inc Publishes Clinical Safety, Tolerability and Effectiveness Data Supporting Advancement of Its Autologous NK Cell Pipeline Using an In-House Developed Culture Protocol
February 22, 2026
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
January 30, 2026
Alps Group Inc Appoints Cheing Lye-Ping as Chief Financial Officer
January 7, 2026